Search
Descriptor English: Moxisylyte
Descriptor Spanish: Moxisilita
Descriptor moxisilita
Entry term(s) timoxamina
timoxialcilamina
Scope note: Bloqueante adrenérgico alfa utilizado en la enfermedad de Raynaud. También se utiliza ltópicamente en los ojos para revertir la midriasis causada por la fenilefrina y otros agentes simpaticomiméticos. (Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Descriptor Portuguese: Moxisilita
Descriptor French: Moxisylyte
Entry term(s): Acetoxythymoxamine
Carlytène
Hydrochloride, Moxisylyte
Icavex
Moxisylyte Hydrochloride
Thymoxamine
Thymoxyalcylamine
Tree number(s): D02.092.668.387.500
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D013948
Scope note: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Adrenergic alpha-Antagonists
Miotics
Sympatholytics
Vasodilator Agents
Registry Number: PW8QYA7KI0
CAS Type 1 Name: Phenol, 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)-, acetate (ester)
Previous Indexing: Carvacrol (1966-1971)
Sympatholytics (1966-1971)
Public MeSH Note: 93; was THYMOXAMINE 1972-92; MOXISYLYTE was see THYMOXAMINE 1976-92
Online Note: use MOXISYLYTE to search THYMOXAMINE 1972-92 (as Prov 1972)
History Note: 93; was THYMOXAMINE 1972-92 (Prov 1972); MOXISYLYTE was see THYMOXAMINE 1976-92
DeCS ID: 30909
Unique ID: D013948
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1973/01/01
Date of Entry: 1999/01/01
Revision Date: 2016/07/01
Moxisylyte - Preferred
Concept UI M0021466
Scope note An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Preferred term Moxisylyte
Entry term(s) Acetoxythymoxamine
Thymoxamine
Thymoxyalcylamine
Moxisylyte Hydrochloride - Narrower
Concept UI M0474459
Preferred term Moxisylyte Hydrochloride
Entry term(s) Hydrochloride, Moxisylyte
Carlytène - Narrower
Concept UI M0474460
Preferred term Carlytène
Icavex - Narrower
Concept UI M0474461
Preferred term Icavex



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey